Abstract
There is a body of evidence suggesting that mitochondrial dysfunction is involved in bipolar disorder (BD) pathogenesis. Studies suggest that abnormalities in circadian cycles are involved in the pathophysiology of affective disorders; paradoxical sleep deprivation (PSD) induces hyperlocomotion in mice. Thus, the present study aims to investigate the effects of lithium (Li) and valproate (VPA) in an animal model of mania induced by PSD for 96 h. PSD increased exploratory activity, and mood stabilizers prevented PSD-induced behavioral effects. PSD also induced a significant decrease in the activity of complex II–III in hippocampus and striatum; complex IV activity was decreased in prefrontal cortex, cerebellum, hippocampus, striatum and cerebral cortex. Additionally, VPA administration was able to prevent PSD-induced inhibition of complex II–III and IV activities in prefrontal cortex, cerebellum, hippocampus, striatum and cerebral cortex, whereas Li administration prevented PSD-induced inhibition only in prefrontal cortex and hippocampus. Regarding the enzymes of Krebs cycle, only citrate synthase activity was increased by PSD in prefrontal cortex. We also found a similar effect in creatine kinase, an important enzyme that acts in the buffering of ATP levels in brain; its activity was increased in prefrontal cortex, hippocampus and cerebral cortex. These results are consistent with the connection of mitochondrial dysfunction and hyperactivity in BD and suggest that the present model fulfills adequate face, construct and predictive validity as an animal model of mania.
Similar content being viewed by others
References
Tufik S, Andersen ML, Bittencourt LR, Mello MT (2009) Paradoxical sleep deprivation: neurochemical, hormonal and behavioral alterations. Evidence from 30 years of research. Anais da Academia Brasileira de Ciências 81:521–538
Koban M, Swinson KL (2005) Chronic REM-sleep deprivation of rats elevates metabolic rate and increases UCP1 gene expression in brown adipose tissue. Am J Physiol Endocrinol Metab 289:68–74
Rechtschaffen A, Gilliland MA, Bergmann BM, Winter JB (1983) Physiological correlates of prolonged sleep deprivation in rats. Science 221:182–184
Harvey AG (2008) Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 165:820–829
El-Mallakh RS, El-Masri MA, Huff MO, Li XP, Decker S, Levy RS (2003) Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 5:362–365
Squassina A, Manchia M, Del Zompo M (2010) Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder. Hum Genomics Proteomics 2010:159761
Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA (2009) Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 65:489–494
Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, Ye NZ, Froimowitz MP, Hassinger LC, Menesale EB, Sargent LW, Logan DJ, Carpenter AE, Cohen BM (2010) Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 177:575–585
Caetano SC, Olvera RL, Hatch JP, Sanches M, Chen HH, Nicoletti M, Stanley JA, Fonseca M, Hunter K, Lafer B, Pliszka SR, Soares JC (2011) Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a 1H magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry 50:85–94
Regenold WT, Pratt M, Nekkalapu S, Shapiro PS, Kristian T, Fiskum G (2012) Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy and neurotrophic signaling. J Psychiatr Res 46:95–104
Corrêa C, Amboni G, Assis LC, Martins MR, Kapczinski F, Streck EL, Quevedo J (2007) Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 31:887–891
Streck EL, Amboni G, Scaini G, Di-Pietro PB, Rezin GT, Valvassori SS, Luz G, Kapczinski F, Quevedo J (2008) Brain creatine kinase activity in an animal model of mania. Life Sci 82:424–429
Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Gonçalves CL, Cardoso MR, Streck EL, Kapczinski F, Quevedo J (2010) Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 44:903–909
Feier G, Valvassori SS, Varela RB, Resende WR, Bavaresco DV, Morais MO, Scaini G, Andersen ML, Streck EL, Quevedo J (2013) Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine. Pharmacol Biochem Behav 103:589–596
Rezin GT, Furlanetto CB, Scaini G, Valvassori SS, Gonçalves CL, Ferreira GK, Jeremias IC, Resende WR, Cardoso MR, Varela RB, Quevedo J, Streck EL (2014) Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania. Mol Neurobiol 49(2):877–892
Machado RB, Hipolide DC, Benedito-Silva AA, Tufik S (2004) Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res 1004:45–51
Ruiz FS, Andersen ML, Zager A, Martins RC, Tufik S (2007) Sleep deprivation reduces the lymphocyte count in a non-obese mouse model of type 1 diabetes mellitus. Braz J Med Biol Res 40:633–637
Tufik S, Lindsey CJ, Carlini EA (1978) Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain? Pharmacology 16:98–105
Zager A, Andersen ML, Lima MM, Reksidler AB, Machado RB, Tufik S (2009) Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice. Eur Neuropsychopharmacol 19:589–602
Lowry OH, Rosebough NG, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Srere PA (1969) Citrate synthase. Methods Enzymol 13:3–11
Kitto GB (1969) Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods Enzymol 13:106–116
Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23–36
Cassina A, Radi R (1996) Differential inhibitory Aation of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328:309–316
Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51
Hughes BP (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7:597–603
Mcewen BS (2006) Sleep deprivation as a neurobiologic and psychologic stressor: allostasis and allostatic load. Metabolism 55:S20–S23
Wehr T (1990) Effects of wakefulness and sleep on depression and mania. In: Mountplaisir J, Godbout R (eds) Sleep and biological rhythms: basic mechanisms and applications to psychiatry. Oxford University Press, Oxford, pp 42–86
Hudson JI, Lipinski JF, Keck PE Jr, Aizley HG, Lukas SE, Rothschild AJ, Waternaux CM, Kupfer DJ (1992) Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry 49:378–383
Lauer CJ, Schreiber W, Holsboer F, Krieg JC (1995) In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry 52:145–153
Buckley TM, Schatzberg AF (2005) On the interactions of the hypothalamic–pituitary–adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90(5):3106–3114
Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM (2008) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Ver 32(4):675–692
Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter TA, Goldberg JF, Bowden CL, Sachs GS (2004) Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the systematic treatment enhancement program. Am J Psychiatry 161(10):1902–1908
Cervantes P, Gelber S, Kin FN, Nair VN, Schwartz G (2001) Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 26(5):411–416
Deshauer D, Grof E, Alda M, Grof P (1999) Patterns of DST positivity in remitted affective disorders. Biol Psychiatry 45:1023–1029
Armani F, Andersen ML, Andreatini R, Frussa-Filho R, Tufik S, Galduróz JC (2012) Successful combined therapy with tamoxifen and lithium in a paradoxical sleep deprivation-induced mania model. CNS Neurosci Ther 18(2):119–125
Baxter LR Jr, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM (1985) Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry 42:441–447
Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450–458
Deicken RF, Weiner MW, Fein G (1995) Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 33:195–199
Kato T, Takahashi S, Shioiri T, Inubushi T (1993) Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 27:53–59
Kato T, Inubushi T, Kato N (1998) Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 10:133–147
Stork C, Renshaw PF (2005) Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10:900–919
Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300–308
Sun X, Wang JF, Tseng M, Young LT (2006) Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 31:189–196
Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180–190
Amar S, Shamir A, Ovadia O, Blanaru M, Reshef A, Kremer I, Rietschel M, Schulze TG, Maier W, Belmaker RH, Ebstein RP, Agam G, Mishmar D (2007) Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs. Schizophr Res 94:354–358
Kato T, Stine OC, McMahon FJ, Crowe RR (1997) Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry 42:871–875
Kato T, Kunugi H, Nanko S, Kato N (2000) Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. Am J Med Genet 96:182–186
Munakata K, Tanaka M, Mori K, Washizuka S, Yoneda M, Tajima O, Akiyama T, Nanko S, Kunugi H, Tadokoro K, Ozaki N, Inada T, Sakamoto K, Fukunaga T, Iijima Y, Iwata N, Tatsumi M, Yamada K, Yoshikawa T, Kato T (2004) Mitochondrial DNA 3644T→C mutation associated with bipolar disorder. Genomics 84:1041–1050
Munakata K, Iwamoto K, Bundo M, Kato T (2005) Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry 57:525–532
Quiroz JA, Gray NA, Kato T, Manji HK (2008) Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33:2551–2565
Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Wallace DC, Bunney WE, Vawter MP (2009) Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS ONE 4:e4913
Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP (2008) Mitochondrial involvement in psychiatric disorders. Ann Med 40:281–295
Ueno H, Nishigaki Y, Kong QP, Fuku N, Kojima S, Iwata N, Ozaki N, Tanaka M (2009) Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. Mitochondrion 9:385–393
Andreazza AC, Andersen ML, Alvarenga TA, de-Oliveira MR, Armani F, Ruiz FS, Giglio L, Moreira JC, Kapczinski F, Tufik S (2010) Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice. J Psychiatry Res 44:775–780
Adam-Vizi V (2005) Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 7:1140–1149
Navarro A, Boveris A (2007) The mitochondrial energy transduction system and the aging process. Am J Cell Physiol 292:670–686
Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B (2007) The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Physiol Cell Physiol 293:C12–C21
Khadrawy YA, Nour NA, Aboul Ezz HS (2011) Effect of oxidative stress induced by paradoxical sleep deprivation on the activities of Na+, K+-ATPase and acetylcholinesterase in the cortex and hippocampus of rat. Transl Res 157:100–107
Nikonova EV, Naidoo N, Zhang L, Romer M, Cater JR, Scharf MT, Galante RJ, Pack AI (2010) Changes in components of energy regulation in mouse cortex with increases in wakefulness. Sleep 33(7):889–900
Cheng JT, Zhang Q, Qiao P (2004) Apoptosis of hippocampus neurons and upexpression of related gene induced by sleep deprivation in rats. Basic Med Sci Clin 24:205–208
Eilan MM, Gilliland M, Bergnmnn BM (1995) Neuronal degeneration in sleep deprivation rats. Sleep 2:21–24
Yang RH, Hu SJ, Wang Y, Zhang WB, Luo WJ, Chen JY (2008) Paradoxical sleep deprivation impairs spatial learning and affects membrane excitability and mitochondrial protein in the hippocampus. Brain Res 1230:224–232
Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689–695
Djuricic B, Masirevic G, Susicm V (1977) Paradoxical sleep deprivation: effects on brain energy metabolism. Arch Int Physiol Biochim 85:213–219
Bessman SP, Carpenter CL (1985) The Creatine–Creatine phosphate energy shuttle. Annu Rev Biochem 54:831–865
Schnyder T, Gross H, Winkler H (1991) Crystallization of mitochondrial creatine kinase. Growing of large protein crystals and electron microscopic investigation of microcrystals consisting of octamers. J Biol Chem 266:5318–5322
Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compartmentation, structure and function of Creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphoCreatine circuit’ for cellular energy homeostasis. Biochem J 281:21–40
Shao L, Young LT, Wang JF (2005) Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58:879–884
Shalbuyeva N, Brustovetsky T, Brustovetsky N (2007) Lithium desensitizes brain mitochondria to calcium, antagonizes permeability transition, and diminishes cytochrome C release. J Biol Chem 282:18057–18068
Kazuno AA, Munakata K, Kato N, Kato T (2008) Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids. Int J Neuropsychopharmacol 11:71–78
Luis PB, Ruiter JP, Aires CC, Soveral G, de Almeida IT, Duran M, Wanders RJ, Silva MF (2007) Valproic acid metabolites inhibit dihydroplipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation. Biochim Biophys Acta 1767:1126–1133
Bachmann RF, Wang Y, Yuan P, Zhou R, Li X, Alesci S, Du J, Manji HK (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine induced mitochondrial damage. Int J Neuropsychopharmacol 12:805–822
Machado-Vieira R, Ibrahim L, Zarate CA Jr (2011) Histone deacetylases and mood disorders: epigenetic programming in gene–environment interactions. CNS Neurosci Ther 17:699–704
Chen H, Dzitoyeva S, Manev H (2012) Effect of valproic acid on mitochondrial epigenetics. Eur J Pharmacol 690:51–59
Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, Moreira JC, de Bittencourt Pasquali MA, Fries GR, Quevedo J, Gama CS, Post R (2011) Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45(2):156–161
Pfaffenseller B, Fries GR, Wollenhaupt-Aguiar B, Colpo GD, Stertz L, Panizzutti B, Magalhães PV, Kapczinski F (2013) Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev Neurother 13(7):827–842
Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA (2009) Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 65(6):489–494
Acknowledgments
Laboratório de Bioenergética and Laboratório de Neurociências (Brazil) are centers of the National Institute for Translational Medicine (INCT-TM) as well as members of the Center of Excellence in Applied Neurosciences of Santa Catarina (NENASC). This research was supported by grants from CNPq (ELS, JQ, MLA and FK), FAPESC (JQ and ELS), Instituto Cérebro e Mente (JQ and ELS) and UNESC (JQ and EST). ELS, FK, MLA, GTR and JQ are CNPq Research Fellows. CLG, GZR WRR and GZR are holders of a CAPES studentship, GS and SSV is holder of a CNPq studentship, and GKF is holder of a FAPESC studentship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Streck, E.L., Scaini, G., Jeremias, G.C. et al. Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation. Neurochem Res 40, 1144–1152 (2015). https://doi.org/10.1007/s11064-015-1575-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-015-1575-4